Patricia Espinoza-Lopez

Apr 14, 2023 | thelancet.com | Emily MacLean |Emily Maclean |Mikashmi Kohli |Patricia Espinoza-Lopez |Tatiana Caceres

SummaryBackgroundIntegrated molecular testing could be an opportunity to detect and provide care for both tuberculosis and COVID-19. Many high tuberculosis burden countries, such as Peru, have existing GeneXpert systems for tuberculosis testing with GeneXpert Xpert MTB/RIF Ultra (Xpert Ultra), and a GeneXpert SARS-CoV-2 assay, GeneXpert Xpert Xpress SARS-CoV-2 (Xpert Xpress), is also available.